Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
Auriga Reiterates a 'Buy' on 3SBio (SSRX); Raising PT on Strong Q4 and Promising JV
Auriga Upgrades 3SBio (SSRX) to Buy
Auriga Starts 3SBio (SSRX) at Hold; High Growth Biotech Company in China, But Fairly Valued